Distinct neutralization profile of spike variants by antibodies induced upon SARS‐CoV ‐2 infection or vaccination-Reference-Cited by-同舟云学术

Distinct neutralization profile of spike variants by antibodies induced upon SARS‐CoV ‐2 infection or vaccination

Published:2021-11-05 Issue:1 Volume:97 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Rosati Margherita¹^ORCID,Terpos Evangelos²^ORCID,Agarwal Mahesh³,Karalis Vangelis⁴,Bear Jenifer³^ORCID,Burns Robert³,Hu Xintao³^ORCID,Papademetriou Demetrios¹^ORCID,Ntanasis‐Stathopoulos Ioannis²^ORCID,Trougakos Ioannis P.⁵^ORCID,Dimopoulos Meletios‐Athanasios²^ORCID,Pavlakis George N.¹^ORCID,Felber Barbara K.³^ORCID

Affiliation:

1. Human Retrovirus Section, Vaccine Branch, Center for Cancer Research National Cancer Institute Frederick Maryland USA

2. Department of Clinical Therapeutics, School of Medicine National and Kapodistrian University of Athens Athens Greece

3. Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research National Cancer Institute Frederick Maryland USA

4. Department of Pharmacy, School of Health Sciences National and Kapodistrian University of Athens Athens Greece

5. Department of Cell Biology and Biophysics, Faculty of Biology National and Kapodistrian University of Athens Athens Greece

Funder

Department of Health and Human Services, State Government of Victoria

National Cancer Institute

National Institutes of Health

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26380

Reference17 articles.

1. Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients

2. Terpos E Politou M Sergentanis TN et al. Anti‐SARS‐CoV‐2 antibody responses in convalescent plasma donors are increased in hospitalized Patients; Subanalyses of a phase 2 clinical study. Microorganisms. 2020;8:1885.

3. Terpos E Stellas D Rosati M et al. SARS‐CoV‐2 antibody kinetics eight months from COVID‐19 οnset: persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors. Eur J Intern Med. 2021;89:87‐96.

4. Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques

5. Robbiani DF Gaebler C Muecksch F et al. Convergent antibody responses to SARS‐CoV‐2 in convalescent individuals. Nature. 2020;584:437‐442.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal Analysis of Antibody Response Following SARS-CoV-2 Infection Depending on Disease Severity: A Prospective Cohort Study;Viruses;2023-11-13

2. Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN);Leukemia;2023-05-04

3. Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis;Cancers;2023-04-12

4. Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies;European Journal of Internal Medicine;2023-01

5. Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques;Frontiers in Immunology;2022-07-22